Free Delivery Over $100
|
|
|||
|
||||
OverviewAt present, human society is facing a health care crisis that is affecting patients worldwide. In the United States, it is generally believed that the major problem is lack of affordable access to health care (i.e. health insurance). This book takes an unprecedented approach to address this issue by proposing that the major problem is not lack of affordable access to health care per se, but lack of access to better, safer, and more affordable medicines. The latter problem is present not only in the United States and the developing world but also in countries with socialized health care systems, such as Europe and the rest of the industrialized world. This book provides a comparative analysis of the health care systems throughout the world and also examines the biotechnology and pharmaceutical industries. Full Product DetailsAuthor: Ibis Sanchez Serrano (President and Founder, The Core Model Corporation, S.A., Panama City, Panama)Publisher: Elsevier Science Publishing Co Inc Imprint: Elsevier Science Publishing Co Inc Dimensions: Width: 15.20cm , Height: 1.80cm , Length: 22.90cm Weight: 0.620kg ISBN: 9780123918758ISBN 10: 0123918758 Pages: 296 Publication Date: 06 July 2011 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: In Print  This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsPART I: THE GLOBAL HEALTH CARE CRISIS 1. The World’s Health Care Crisis: The United States’ Leadership 2. The Health Care Crisis in Other Parts of the World PART II: UNDERSTANDING THE BIOPHARMACEUTICAL BUSINESS 3. Brief Commercial History of the Biopharmaceutical Industry up to the Year 2000 4. The Biopharmaceutical Industry in the Twenty-first Century: Titanic Challenges Ahead 5. Understanding Research and Development and Marketing in a Biopharmaceutical Company 6. The Pharmaceutical Regulators PART III: THE COMPLEXITY OF INNOVATION 7. The Academia-Industry Relationship 8. Translating Academic Innovation into Health Care Products 9. The Biotechnology World and Its Challenges 10. Causes of the Pharmaceutical Crisis PART IV: MORALITY AND DUTY ON A LONELY PLANET 11. Wealth versus Poverty 12. Social Responsibility, Governmental Role, and Nongovernmental Organizations PART V: REINVENTING RESEARCH AND DEVELOPMENT 13. Time for ReorganizationReviewsThis book is an excellent summary of the health-care crisis facing the world today, comparing health care in wealthy, industrial countries to that in poor, underdeveloped countries. S nchez-Serrano, a Panamian health-care adviser/consultant, covers the history of health care, including pharmaceutically driven treatments; challenges with new drug discoveries; unmet medical needs; and profits. The author also emphasizes the high cost of research and development for new drugs. He explores the issues related to government-supplemented research and summarizes the interaction of government-sponsored basic research, academic (pure) science research, venture capital investors, and industry. The author provides many specific examples of successes and failures of past/present systems and discusses the evolution of pharmaceutical company philosophies in the past 150 years and future challenges. This book is fact based and nonpartisan. The only areas not explored are the modern diagnostics industry, the phenomenal advances in medical devices, and the cost of modern physician care (and the cost of physicians' education). Summing Up: Highly Recommended --CHOICE This book is an excellent summary of the health-care crisis facing the world today, comparing health care in wealthy, industrial countries to that in poor, underdeveloped countries. Sanchez-Serrano, a Panamian health-care adviser/consultant, covers the history of health care, including pharmaceutically driven treatments; challenges with new drug discoveries; unmet medical needs; and profits. The author also emphasizes the high cost of research and development for new drugs. He explores the issues related to government-supplemented research and summarizes the interaction of government-sponsored basic research, academic (pure) science research, venture capital investors, and industry. The author provides many specific examples of successes and failures of past/present systems and discusses the evolution of pharmaceutical company philosophies in the past 150 years and future challenges. This book is fact based and nonpartisan. The only areas not explored are the modern diagnostics industry, the phenomenal advances in medical devices, and the cost of modern physician care (and the cost of physicians' education). Summing Up: Highly Recommended --CHOICE Author InformationIbis Sánchez-Serrano is a world-leading expert on global healthcare, pharmaceutical innovation, and translational science policy. He is a member of the Editorial Board of the journal Gender & the Genome and has written two books, The World’s Health Care Crisis: From the Laboratory Bench to the Patient’s Bedside (Elsevier, 2011) and The Core Model: A Collaborative Paradigm for the Pharmaceutical Industry and Global Health Care (Elsevier, 2019). Mr. Sánchez-Serrano has built a reputation amongst important international government bodies as an expert on the world’s healthcare crisis and the relevant solutions. He’s a frequent speaker on global health care and pharmaceutical development and received international recognitions for his work on global health care, including a “Fulbright Recognition Award and media coverage including CNN, C-SPAN, UNIVISION, EFE Agency, Deutsche Presse Agentur. His research interests include Health Care, Pharmaceuticals, Biotechnology, Public Health, Academia-Industry Relationship, Drug Discovery and Development, Organization and Management of R&D. Tab Content 6Author Website:Countries AvailableAll regions |
||||
